Fibrin hydrogels are safe, degradable scaffolds for sub-retinal implantation
- PMID:31929571
- PMCID: PMC6957177
- DOI: 10.1371/journal.pone.0227641
Fibrin hydrogels are safe, degradable scaffolds for sub-retinal implantation
Abstract
Retinal pigment epithelium (RPE) transplantation for the treatment of macular degeneration has been studied for over 30 years. Human clinical trials have demonstrated that RPE monolayers exhibit improved cellular engraftment and survival compared to single cell suspensions. The use of a scaffold facilitates implantation of a flat, wrinkle-free, precisely placed monolayer. Scaffolds currently being investigated in human clinical trials are non-degradable which results in the introduction of a chronic foreign body. To improve RPE transplant technology, a degradable scaffold would be desirable. Using human fibrin, we have generated scaffolds that support the growth of an RPE monolayer in vitro. To determine whether these scaffolds are degraded in vivo, we developed a surgical approach that delivers a fibrin hydrogel implant to the sub-retinal space of the pig eye and determined whether and how fast they degraded. Using standard ophthalmic imaging techniques, the fibrin scaffolds were completely degraded by postoperative week 8 in 5 of 6 animals. Postmortem histologic analysis confirmed the absence of the scaffold from the subretinal space at 8 weeks, and demonstrated the reattachment of the neurosensory retina and a normal RPE-photoreceptor interface. When mechanical debridement of a region of native RPE was performed during implantation surgery degradation was accelerated and scaffolds were undetectable by 4 weeks. These data represent the first in situ demonstration of a fully biodegradable scaffold for use in the implantation of RPE and other cell types for treatment of macular degeneration and other retinal degenerative diseases.
Conflict of interest statement
JSP and ADM have ownership interests in LAgen Laboratories LLC. ADM serves as CEO of LAgen Laboratories LLC. TWO has ownership of iMacular Regeneration LLC, none of the technology used in this study is relevant. However, none of the disclosures pertain directly to this paper and none of the companies provided financial support for this paper.
Figures






Similar articles
- Fibrin hydrogels as a xenofree and rapidly degradable support for transplantation of retinal pigment epithelium monolayers.Gandhi JK, Manzar Z, Bachman LA, Andrews-Pfannkoch C, Knudsen T, Hill M, Schmidt H, Iezzi R, Pulido JS, Marmorstein AD.Gandhi JK, et al.Acta Biomater. 2018 Feb;67:134-146. doi: 10.1016/j.actbio.2017.11.058. Epub 2017 Dec 9.Acta Biomater. 2018.PMID:29233750
- Subretinal delivery of ultrathin rigid-elastic cell carriers using a metallic shooter instrument and biodegradable hydrogel encapsulation.Stanzel BV, Liu Z, Brinken R, Braun N, Holz FG, Eter N.Stanzel BV, et al.Invest Ophthalmol Vis Sci. 2012 Jan 31;53(1):490-500. doi: 10.1167/iovs.11-8260.Invest Ophthalmol Vis Sci. 2012.PMID:22167099
- A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space.Hynes SR, Lavik EB.Hynes SR, et al.Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):763-78. doi: 10.1007/s00417-009-1263-7. Epub 2010 Feb 19.Graefes Arch Clin Exp Ophthalmol. 2010.PMID:20169358Review.
- Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography.Liu Z, Yu N, Holz FG, Yang F, Stanzel BV.Liu Z, et al.Biomaterials. 2014 Mar;35(9):2837-50. doi: 10.1016/j.biomaterials.2013.12.069. Epub 2014 Jan 15.Biomaterials. 2014.PMID:24439407
- Advances in retinal pigment epithelial cell transplantation for retinal degenerative diseases.Liu H, Huang SS, Lingam G, Kai D, Su X, Liu Z.Liu H, et al.Stem Cell Res Ther. 2024 Oct 31;15(1):390. doi: 10.1186/s13287-024-04007-5.Stem Cell Res Ther. 2024.PMID:39482729Free PMC article.Review.
Cited by
- Trends of Stem Cell Therapies in Age-Related Macular Degeneration.Maeda T, Sugita S, Kurimoto Y, Takahashi M.Maeda T, et al.J Clin Med. 2021 Apr 20;10(8):1785. doi: 10.3390/jcm10081785.J Clin Med. 2021.PMID:33923985Free PMC article.Review.
- New Perspectives in Stem Cell Transplantation and Associated Therapies to Treat Retinal Diseases: From Gene Editing to 3D Bioprinting.Bovi Dos Santos G, de Lima-Vasconcellos TH, Móvio MI, Birbrair A, Del Debbio CB, Kihara AH.Bovi Dos Santos G, et al.Stem Cell Rev Rep. 2024 Apr;20(3):722-737. doi: 10.1007/s12015-024-10689-4. Epub 2024 Feb 6.Stem Cell Rev Rep. 2024.PMID:38319527Review.
- Subretinal Implantation of Human Primary RPE Cells Cultured on Nanofibrous Membranes in Minipigs.Lytvynchuk L, Ebbert A, Studenovska H, Nagymihály R, Josifovska N, Rais D, Popelka Š, Tichotová L, Nemesh Y, Čížková J, Juhásová J, Juhás Š, Jendelová P, Franeková J, Kozak I, Erceg S, Straňák Z, Müller B, Ellederová Z, Motlík J, Stieger K, Ardan T, Petrovski G.Lytvynchuk L, et al.Biomedicines. 2022 Mar 14;10(3):669. doi: 10.3390/biomedicines10030669.Biomedicines. 2022.PMID:35327471Free PMC article.
- Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD).Sarkar A, Junnuthula V, Dyawanapelly S.Sarkar A, et al.Int J Mol Sci. 2021 Sep 30;22(19):10594. doi: 10.3390/ijms221910594.Int J Mol Sci. 2021.PMID:34638935Free PMC article.Review.
- Targeting Ocular Drug Delivery: An Examination of Local Anatomy and Current Approaches.Dosmar E, Walsh J, Doyel M, Bussett K, Oladipupo A, Amer S, Goebel K.Dosmar E, et al.Bioengineering (Basel). 2022 Jan 17;9(1):41. doi: 10.3390/bioengineering9010041.Bioengineering (Basel). 2022.PMID:35049750Free PMC article.Review.
References
- Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson NC, Desai U. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 1991;22: 102–108. - PubMed
- Johnson AA, Bachman LA, Gilles BJ, Cross SD, Stelzig KE, Resch ZT, et al. Autosomal Recessive Bestrophinopathy Is Not Associated With the Loss of Bestrophin-1 Anion Channel Function in a Patient With a Novel BEST1 Mutation. Investig Opthalmology Vis Sci. 2015;56: 4619 10.1167/iovs.15-16910 - DOI - PMC - PubMed
- Pennington BO, Clegg DO, Melkoumian ZK, Hikita ST. Defined Culture of Human Embryonic Stem Cells and Xeno-Free Derivation of Retinal Pigmented Epithelial Cells on a Novel, Synthetic Substrate: Synthetic Substrate for Stem Cell and RPE Culture. STEM CELLS Transl Med. 2015;4: 165–177. 10.5966/sctm.2014-0179 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources